Search results
Roche's Breast Cancer Drug Cuts Risk of Death by 30% in Phase III
Roche RHHBY announced positive new data from a pre-specified interim analysis of its late-stage breast cancer study on pipeline candidate giredestrant, an investigational, oral, potent
Top Stock Reports for Alphabet, Roche & RTX
Monday, November 24, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet
The Zacks Analyst Blog Highlights Alphabet, Roche, RTX, Crawford United and C&F Financial
For Immediate Release
Chicago, IL – November 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and